SBIR/STTR Research Award

DEVELOPMENT OF AN INTRAFALLOPIAN CONTRACEPTION DEVICE

Award identifier fd094c4d1e072c2fa20bd622cd74e14fbd60eb2ac5ca424f0407b7893c7a9411Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$99,748

Program and phase

SBIR · Phase I

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
E-PRIME, LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Current and foreseeable birth control methods require the user to make life choices involving safety, reliability, or permanent sterilization. The proposed solution is a fallopian tube occlusion device inserted via a hysteroscopic, transcervical procedure. This new device will add a safe, reliable and reversible choice of birth control methods. The device technology is based on modification of an existing shape-memory, polymeric, thermal-sensitive material, which will be rigid at room temperature for easy insertion and become soft and adaptive to the anatomy at body temperature. As this softening occurs, the material will expand to occlude the fallopian tube to prevent the passage of eggs and sperm rendering the patient infertile. The device may be removed to reestablish fertility. Phase I of this project will allow the development of a material formulation to achieve the required physical properties and permit limited feasibility testing. Existing materials are too stiff at body temperature for adaptation with the irregular shape of the human fallopian tube or lack the required strength for removal. Delivery and occlusion functionality will be tested in an animal tissue specimen. Commercialization of the device would be expected to command a significant share of the $3 billion contraceptive market.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.